Skip to main content
Caplight Logo









Constructive Bio

Constructive Bio

Private
CambridgeHealthcare & Life Scienceshttps://constructive.bio/

Last Round

Series A

Extension

Mar 27, 2025

Total Funding Raised

$74.35M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Constructive Bio is a biotechnology company that engineers synthetic genomes and cellular machinery to transform living cells into biofactories for the production of enzymes, pharmaceuticals, and biomaterials.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

synthetic biologygenome engineeringDNA synthesisgenome assemblysynbiosynthetic genomicsmetabolic engineeringbiomanufacturingDNA writingprotein translationplant engineeringsynthetic chloroplastbiotech platformdrug discoverybio-foundry

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Constructive Bio Comparables

Compare Constructive Bio with similar companies based on industry and business-model similarity.

Constructive Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ribbon Bio
80%
Elegen
80%
Camena Bioscience
79%

Constructive Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionMar 27, 2025
GrantMar 5, 2025
Series ASep 24, 2024
SeedAug 15, 2022

Key People

Founding team and executive leadership

Ann Ferry

EA To The CEO

Executive Team

Ola Wlodek

Chief Executive Officer

Executive Team

Constructive Bio Investors

Notable investors and investment history

Constructive Bio investors
InvestorRounds
Innovate UKGrant
Amadeus Capital PartnersSeed
Fine Structure VenturesSeries A
F-Prime CapitalSeries A
+ND CapitalSeries A
Paladin Capital GroupSeries A
LongeVCSeries A, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 11, 2026

    Monthly visitors grew 42% MoM, reaching 4.6K.

  • Oct 10, 2025

    Partnered with the Ellison Institute of Technology and its Generative Biology Institute.

Constructive Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Constructive Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Constructive Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range71
Year Founded2022
Last FundingMar 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?